Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026?
Health & MedicineOne-Off3mndManifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingNee 92.9%
Voorspellers
4
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 7 uur geleden
Verouderd5 sep 23, 09:52 UTC31 dec 26, 22:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
When will Tesla Cybertruck be available in Europe?
Manifold MarketsWill the FDA approve any psychedelic substance for medical use this year?
KalshiWill Drift0r's medical problem be found before 2027?
Manifold MarketsWhat will be true of the explosion at Harvard Medical School?
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiRegels
The clinical trials for fat tissue regrowing implants have already started in France and Spain.
- It is projected to finish in 2025.
- And it will change the silicon paradigm in plastic surgery.
- Will this technology be available for reconstructive or aesthetic breast surgery by the end of 2026 outside of clinical trials?
- https://www.theguardian.com/society/2022/jul/03/breast-reconstruction-cancer-silicone-implants-regrowing
- [link preview]
Open markten
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Totaal volume
- € 15,7 mln.
- 24u volume
- € 52,2K
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 extra uitkomsten
- Totaal volume
- € 870,4K
- 24u volume
- € 2,1K
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Totaal volume
- € 922,5K
- 24u volume
- € 1,8K
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 extra uitkomsten
- Totaal volume
- € 32,4K
- 24u volume
- € 1,3K
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Totaal volume
- € 1,6 mln.
- 24u volume
- € 933,9
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 extra uitkomsten
- Totaal volume
- € 810,1
- 24u volume
- € 767
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Veelgestelde vragen
- Wat zijn de huidige kansen voor Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026??
- Manifold Markets prijst No op 93% per 11 september 2026.
- Wanneer wordt Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? afgewikkeld?
- Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? wordt naar verwachting op 31 december 2026 afgewikkeld.
- Hoe wordt Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? afgewikkeld?
- Manifold Markets wikkelt deze markt als volgt af: The clinical trials for fat tissue regrowing implants have already started in France and Spain.